nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—ADRB2—chronic obstructive pulmonary disease	0.352	1	CbGaD
Bisoprolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0859	0.164	CbGbCtD
Bisoprolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0846	0.161	CbGbCtD
Bisoprolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0651	0.124	CbGbCtD
Bisoprolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0651	0.124	CbGbCtD
Bisoprolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0641	0.122	CbGbCtD
Bisoprolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0641	0.122	CbGbCtD
Bisoprolol—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0163	0.0311	CbGbCtD
Bisoprolol—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0163	0.0311	CbGbCtD
Bisoprolol—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0146	0.0277	CbGbCtD
Bisoprolol—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0137	0.0261	CbGbCtD
Bisoprolol—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00925	0.0176	CbGbCtD
Bisoprolol—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00883	0.0168	CbGbCtD
Bisoprolol—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00787	0.015	CbGbCtD
Bisoprolol—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00462	0.0088	CbGbCtD
Bisoprolol—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00436	0.00831	CbGbCtD
Bisoprolol—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000714	0.0657	CbGpPWpGaD
Bisoprolol—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.000631	0.0581	CbGpPWpGaD
Bisoprolol—ADRB1—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.00058	0.0534	CbGpPWpGaD
Bisoprolol—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.000516	0.0475	CbGpPWpGaD
Bisoprolol—Esmolol—ADRB2—chronic obstructive pulmonary disease	0.000414	0.111	CrCbGaD
Bisoprolol—Bevantolol—ADRB2—chronic obstructive pulmonary disease	0.000409	0.109	CrCbGaD
Bisoprolol—Betaxolol—ADRB2—chronic obstructive pulmonary disease	0.000364	0.0975	CrCbGaD
Bisoprolol—Atenolol—ADRB2—chronic obstructive pulmonary disease	0.000361	0.0966	CrCbGaD
Bisoprolol—Acebutolol—ADRB2—chronic obstructive pulmonary disease	0.000333	0.0892	CrCbGaD
Bisoprolol—Oxprenolol—ADRB2—chronic obstructive pulmonary disease	0.000331	0.0885	CrCbGaD
Bisoprolol—Alprenolol—ADRB2—chronic obstructive pulmonary disease	0.000302	0.081	CrCbGaD
Bisoprolol—Betaxolol—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.0806	CrCbGaD
Bisoprolol—Metoprolol—ADRB2—chronic obstructive pulmonary disease	0.000281	0.0753	CrCbGaD
Bisoprolol—ADRB1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000262	0.0241	CbGpPWpGaD
Bisoprolol—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000262	0.0241	CbGpPWpGaD
Bisoprolol—Pindolol—ADRB2—chronic obstructive pulmonary disease	0.00026	0.0696	CrCbGaD
Bisoprolol—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000207	0.019	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000205	0.0189	CbGpPWpGaD
Bisoprolol—ADRB1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000203	0.0187	CbGpPWpGaD
Bisoprolol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000201	0.0185	CbGpPWpGaD
Bisoprolol—ADRB1—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000191	0.0175	CbGpPWpGaD
Bisoprolol—ADRB1—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	0.000183	0.0169	CbGpPWpGaD
Bisoprolol—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.0159	CbGpPWpGaD
Bisoprolol—ADRB1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000173	0.0159	CbGpPWpGaD
Bisoprolol—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000166	0.0153	CbGpPWpGaD
Bisoprolol—ADRB1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00016	0.0148	CbGpPWpGaD
Bisoprolol—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000157	0.0145	CbGpPWpGaD
Bisoprolol—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.0143	CbGpPWpGaD
Bisoprolol—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00015	0.0138	CbGpPWpGaD
Bisoprolol—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00135	CcSEcCtD
Bisoprolol—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000146	0.00134	CcSEcCtD
Bisoprolol—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00134	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000145	0.00134	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000145	0.00134	CcSEcCtD
Bisoprolol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00133	CcSEcCtD
Bisoprolol—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00132	CcSEcCtD
Bisoprolol—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00132	CcSEcCtD
Bisoprolol—Infection—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00131	CcSEcCtD
Bisoprolol—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00131	CcSEcCtD
Bisoprolol—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000142	0.0131	CbGpPWpGaD
Bisoprolol—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000142	0.038	CrCbGaD
Bisoprolol—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.0013	CcSEcCtD
Bisoprolol—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.0013	CcSEcCtD
Bisoprolol—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.0013	CcSEcCtD
Bisoprolol—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.0013	CcSEcCtD
Bisoprolol—ADRB1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000141	0.013	CbGpPWpGaD
Bisoprolol—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000141	0.0013	CcSEcCtD
Bisoprolol—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.00129	CcSEcCtD
Bisoprolol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00129	CcSEcCtD
Bisoprolol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00129	CcSEcCtD
Bisoprolol—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00129	CcSEcCtD
Bisoprolol—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00129	CcSEcCtD
Bisoprolol—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00129	CcSEcCtD
Bisoprolol—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00129	CcSEcCtD
Bisoprolol—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.00128	CcSEcCtD
Bisoprolol—Infection—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00128	CcSEcCtD
Bisoprolol—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.00128	CcSEcCtD
Bisoprolol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00128	CcSEcCtD
Bisoprolol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00128	CcSEcCtD
Bisoprolol—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000139	0.00128	CcSEcCtD
Bisoprolol—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00127	CcSEcCtD
Bisoprolol—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000138	0.0127	CbGpPWpGaD
Bisoprolol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00127	CcSEcCtD
Bisoprolol—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00127	CcSEcCtD
Bisoprolol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00126	CcSEcCtD
Bisoprolol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.0124	CbGpPWpGaD
Bisoprolol—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00125	CcSEcCtD
Bisoprolol—ADRB1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000135	0.0124	CbGpPWpGaD
Bisoprolol—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00124	CcSEcCtD
Bisoprolol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00123	CcSEcCtD
Bisoprolol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00123	CcSEcCtD
Bisoprolol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.00123	CcSEcCtD
Bisoprolol—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00123	CcSEcCtD
Bisoprolol—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00122	CcSEcCtD
Bisoprolol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00122	CcSEcCtD
Bisoprolol—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000132	0.0121	CbGpPWpGaD
Bisoprolol—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00122	CcSEcCtD
Bisoprolol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00121	CcSEcCtD
Bisoprolol—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000131	0.0012	CcSEcCtD
Bisoprolol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.0012	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00013	0.0012	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.0012	CcSEcCtD
Bisoprolol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00119	CcSEcCtD
Bisoprolol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00119	CcSEcCtD
Bisoprolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.00119	CcSEcCtD
Bisoprolol—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000129	0.0118	CbGpPWpGaD
Bisoprolol—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00118	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000128	0.00118	CcSEcCtD
Bisoprolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00118	CcSEcCtD
Bisoprolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00118	CcSEcCtD
Bisoprolol—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00117	CcSEcCtD
Bisoprolol—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00117	CcSEcCtD
Bisoprolol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00117	CcSEcCtD
Bisoprolol—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00116	CcSEcCtD
Bisoprolol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00116	CcSEcCtD
Bisoprolol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00116	CcSEcCtD
Bisoprolol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00116	CcSEcCtD
Bisoprolol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00116	CcSEcCtD
Bisoprolol—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.0116	CbGpPWpGaD
Bisoprolol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.00116	CcSEcCtD
Bisoprolol—Injury—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00115	CcSEcCtD
Bisoprolol—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00115	CcSEcCtD
Bisoprolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000124	0.00115	CcSEcCtD
Bisoprolol—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00114	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00114	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00114	CcSEcCtD
Bisoprolol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000123	0.00114	CcSEcCtD
Bisoprolol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00114	CcSEcCtD
Bisoprolol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00114	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00113	CcSEcCtD
Bisoprolol—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000123	0.0113	CbGpPWpGaD
Bisoprolol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Bisoprolol—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Bisoprolol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Bisoprolol—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Bisoprolol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00113	CcSEcCtD
Bisoprolol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.0326	CrCbGaD
Bisoprolol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00112	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00112	CcSEcCtD
Bisoprolol—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000121	0.0111	CbGpPWpGaD
Bisoprolol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00111	CcSEcCtD
Bisoprolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00111	CcSEcCtD
Bisoprolol—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00111	CcSEcCtD
Bisoprolol—Pain—Montelukast—chronic obstructive pulmonary disease	0.00012	0.0011	CcSEcCtD
Bisoprolol—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.0011	CcSEcCtD
Bisoprolol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00012	0.0011	CcSEcCtD
Bisoprolol—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.0011	CcSEcCtD
Bisoprolol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.0011	CcSEcCtD
Bisoprolol—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000119	0.0011	CcSEcCtD
Bisoprolol—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.00109	CcSEcCtD
Bisoprolol—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.00109	CcSEcCtD
Bisoprolol—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00109	CcSEcCtD
Bisoprolol—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00109	CcSEcCtD
Bisoprolol—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00109	CcSEcCtD
Bisoprolol—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0108	CbGpPWpGaD
Bisoprolol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000118	0.00109	CcSEcCtD
Bisoprolol—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00108	CcSEcCtD
Bisoprolol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.0314	CrCbGaD
Bisoprolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000117	0.00108	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000117	0.00108	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.00108	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00108	CcSEcCtD
Bisoprolol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.00107	CcSEcCtD
Bisoprolol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00107	CcSEcCtD
Bisoprolol—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00107	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000115	0.00106	CcSEcCtD
Bisoprolol—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000115	0.00106	CcSEcCtD
Bisoprolol—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00105	CcSEcCtD
Bisoprolol—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00105	CcSEcCtD
Bisoprolol—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00104	CcSEcCtD
Bisoprolol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00104	CcSEcCtD
Bisoprolol—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00104	CcSEcCtD
Bisoprolol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00104	CcSEcCtD
Bisoprolol—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.0104	CbGpPWpGaD
Bisoprolol—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00104	CcSEcCtD
Bisoprolol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000113	0.00104	CcSEcCtD
Bisoprolol—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00103	CcSEcCtD
Bisoprolol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	0.000112	0.0103	CbGpPWpGaD
Bisoprolol—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000112	0.00103	CcSEcCtD
Bisoprolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000112	0.00103	CcSEcCtD
Bisoprolol—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00103	CcSEcCtD
Bisoprolol—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00103	CcSEcCtD
Bisoprolol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000111	0.00102	CcSEcCtD
Bisoprolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.00102	CcSEcCtD
Bisoprolol—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00102	CcSEcCtD
Bisoprolol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00102	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00102	CcSEcCtD
Bisoprolol—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000109	0.001	CcSEcCtD
Bisoprolol—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000109	0.01	CbGpPWpGaD
Bisoprolol—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000109	0.001	CcSEcCtD
Bisoprolol—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.00099	CcSEcCtD
Bisoprolol—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000985	CcSEcCtD
Bisoprolol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000985	CcSEcCtD
Bisoprolol—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000972	CcSEcCtD
Bisoprolol—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000972	CcSEcCtD
Bisoprolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000105	0.000971	CcSEcCtD
Bisoprolol—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000969	CcSEcCtD
Bisoprolol—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000952	CcSEcCtD
Bisoprolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.000946	CcSEcCtD
Bisoprolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000103	0.000946	CcSEcCtD
Bisoprolol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.000933	CcSEcCtD
Bisoprolol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000101	0.000933	CcSEcCtD
Bisoprolol—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000932	CcSEcCtD
Bisoprolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000101	0.000927	CcSEcCtD
Bisoprolol—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	9.97e-05	0.00917	CbGpPWpGaD
Bisoprolol—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.96e-05	0.000918	CcSEcCtD
Bisoprolol—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.92e-05	0.000914	CcSEcCtD
Bisoprolol—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	9.83e-05	0.00904	CbGpPWpGaD
Bisoprolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.79e-05	0.000903	CcSEcCtD
Bisoprolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.79e-05	0.000903	CcSEcCtD
Bisoprolol—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	9.75e-05	0.000898	CcSEcCtD
Bisoprolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	9.7e-05	0.000894	CcSEcCtD
Bisoprolol—Sweating increased—Prednisone—chronic obstructive pulmonary disease	9.65e-05	0.000889	CcSEcCtD
Bisoprolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	9.59e-05	0.000884	CcSEcCtD
Bisoprolol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	9.56e-05	0.000881	CcSEcCtD
Bisoprolol—Erythema—Prednisolone—chronic obstructive pulmonary disease	9.5e-05	0.000875	CcSEcCtD
Bisoprolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	9.47e-05	0.000872	CcSEcCtD
Bisoprolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	9.47e-05	0.000872	CcSEcCtD
Bisoprolol—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	9.43e-05	0.00868	CbGpPWpGaD
Bisoprolol—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	9.34e-05	0.0086	CbGpPWpGaD
Bisoprolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	9.27e-05	0.000854	CcSEcCtD
Bisoprolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	9.25e-05	0.000852	CcSEcCtD
Bisoprolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000841	CcSEcCtD
Bisoprolol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.1e-05	0.000839	CcSEcCtD
Bisoprolol—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.1e-05	0.000839	CcSEcCtD
Bisoprolol—Rash—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.000832	CcSEcCtD
Bisoprolol—Rash—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.000832	CcSEcCtD
Bisoprolol—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.02e-05	0.000831	CcSEcCtD
Bisoprolol—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.02e-05	0.000831	CcSEcCtD
Bisoprolol—Weight increased—Prednisone—chronic obstructive pulmonary disease	9.02e-05	0.000831	CcSEcCtD
Bisoprolol—Headache—Formoterol—chronic obstructive pulmonary disease	8.97e-05	0.000826	CcSEcCtD
Bisoprolol—Headache—Arformoterol—chronic obstructive pulmonary disease	8.97e-05	0.000826	CcSEcCtD
Bisoprolol—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	8.94e-05	0.00823	CbGpPWpGaD
Bisoprolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.94e-05	0.000824	CcSEcCtD
Bisoprolol—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.92e-05	0.000822	CcSEcCtD
Bisoprolol—Rash—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.000815	CcSEcCtD
Bisoprolol—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.83e-05	0.000814	CcSEcCtD
Bisoprolol—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.81e-05	0.000812	CcSEcCtD
Bisoprolol—Depression—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000812	CcSEcCtD
Bisoprolol—Headache—Montelukast—chronic obstructive pulmonary disease	8.78e-05	0.000809	CcSEcCtD
Bisoprolol—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000802	CcSEcCtD
Bisoprolol—Angioedema—Prednisolone—chronic obstructive pulmonary disease	8.68e-05	0.0008	CcSEcCtD
Bisoprolol—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000798	CcSEcCtD
Bisoprolol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	8.59e-05	0.000792	CcSEcCtD
Bisoprolol—Malaise—Prednisolone—chronic obstructive pulmonary disease	8.57e-05	0.000789	CcSEcCtD
Bisoprolol—Vertigo—Prednisolone—chronic obstructive pulmonary disease	8.53e-05	0.000786	CcSEcCtD
Bisoprolol—Rash—Salbutamol—chronic obstructive pulmonary disease	8.52e-05	0.000785	CcSEcCtD
Bisoprolol—Syncope—Prednisolone—chronic obstructive pulmonary disease	8.52e-05	0.000785	CcSEcCtD
Bisoprolol—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	8.51e-05	0.000785	CcSEcCtD
Bisoprolol—Nausea—Formoterol—chronic obstructive pulmonary disease	8.5e-05	0.000784	CcSEcCtD
Bisoprolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	8.5e-05	0.000784	CcSEcCtD
Bisoprolol—Headache—Salbutamol—chronic obstructive pulmonary disease	8.47e-05	0.00078	CcSEcCtD
Bisoprolol—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	8.35e-05	0.000769	CcSEcCtD
Bisoprolol—Nausea—Montelukast—chronic obstructive pulmonary disease	8.33e-05	0.000767	CcSEcCtD
Bisoprolol—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	8.22e-05	0.00757	CbGpPWpGaD
Bisoprolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000744	CcSEcCtD
Bisoprolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.03e-05	0.00074	CcSEcCtD
Bisoprolol—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.99e-05	0.000736	CcSEcCtD
Bisoprolol—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	7.9e-05	0.00728	CbGpPWpGaD
Bisoprolol—Hallucination—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000727	CcSEcCtD
Bisoprolol—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.000718	CcSEcCtD
Bisoprolol—Oedema—Prednisolone—chronic obstructive pulmonary disease	7.75e-05	0.000714	CcSEcCtD
Bisoprolol—Shock—Prednisolone—chronic obstructive pulmonary disease	7.63e-05	0.000703	CcSEcCtD
Bisoprolol—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	7.57e-05	0.000697	CcSEcCtD
Bisoprolol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	7.49e-05	0.000691	CcSEcCtD
Bisoprolol—Eye disorder—Prednisone—chronic obstructive pulmonary disease	7.41e-05	0.000683	CcSEcCtD
Bisoprolol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	7.4e-05	0.00681	CbGpPWpGaD
Bisoprolol—Flushing—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000678	CcSEcCtD
Bisoprolol—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	7.35e-05	0.00676	CbGpPWpGaD
Bisoprolol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000663	CcSEcCtD
Bisoprolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	7.18e-05	0.00661	CbGpPWpGaD
Bisoprolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	7.12e-05	0.00655	CbGpPWpGaD
Bisoprolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	7.09e-05	0.00653	CbGpPWpGaD
Bisoprolol—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.000653	CcSEcCtD
Bisoprolol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.01e-05	0.000646	CcSEcCtD
Bisoprolol—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000646	CcSEcCtD
Bisoprolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	6.97e-05	0.00642	CbGpPWpGaD
Bisoprolol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.96e-05	0.000642	CcSEcCtD
Bisoprolol—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.00064	CcSEcCtD
Bisoprolol—Erythema—Prednisone—chronic obstructive pulmonary disease	6.9e-05	0.000636	CcSEcCtD
Bisoprolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	6.76e-05	0.00622	CbGpPWpGaD
Bisoprolol—Pain—Prednisolone—chronic obstructive pulmonary disease	6.63e-05	0.000611	CcSEcCtD
Bisoprolol—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.00059	CcSEcCtD
Bisoprolol—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.39e-05	0.000589	CcSEcCtD
Bisoprolol—Agitation—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.000585	CcSEcCtD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	6.32e-05	0.00581	CbGpPWpGaD
Bisoprolol—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000581	CcSEcCtD
Bisoprolol—Malaise—Prednisone—chronic obstructive pulmonary disease	6.22e-05	0.000574	CcSEcCtD
Bisoprolol—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000571	CcSEcCtD
Bisoprolol—Syncope—Prednisone—chronic obstructive pulmonary disease	6.19e-05	0.00057	CcSEcCtD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	6.18e-05	0.00569	CbGpPWpGaD
Bisoprolol—Urticaria—Prednisolone—chronic obstructive pulmonary disease	6.16e-05	0.000568	CcSEcCtD
Bisoprolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	6.15e-05	0.00566	CbGpPWpGaD
Bisoprolol—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000559	CcSEcCtD
Bisoprolol—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000542	CcSEcCtD
Bisoprolol—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000542	CcSEcCtD
Bisoprolol—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.86e-05	0.00054	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000538	CcSEcCtD
Bisoprolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	5.82e-05	0.00536	CbGpPWpGaD
Bisoprolol—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	5.81e-05	0.00535	CbGpPWpGaD
Bisoprolol—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000535	CcSEcCtD
Bisoprolol—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.71e-05	0.000526	CcSEcCtD
Bisoprolol—Oedema—Prednisone—chronic obstructive pulmonary disease	5.63e-05	0.000519	CcSEcCtD
Bisoprolol—Infection—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000516	CcSEcCtD
Bisoprolol—Shock—Prednisone—chronic obstructive pulmonary disease	5.54e-05	0.000511	CcSEcCtD
Bisoprolol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.52e-05	0.000509	CcSEcCtD
Bisoprolol—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000507	CcSEcCtD
Bisoprolol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.47e-05	0.000504	CcSEcCtD
Bisoprolol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.45e-05	0.000502	CcSEcCtD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	5.41e-05	0.00498	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	5.29e-05	0.00487	CbGpPWpGaD
Bisoprolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.22e-05	0.0048	CbGpPWpGaD
Bisoprolol—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.15e-05	0.00474	CbGpPWpGaD
Bisoprolol—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.13e-05	0.000473	CcSEcCtD
Bisoprolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.13e-05	0.000472	CcSEcCtD
Bisoprolol—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.1e-05	0.00047	CcSEcCtD
Bisoprolol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000466	CcSEcCtD
Bisoprolol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.96e-05	0.000457	CcSEcCtD
Bisoprolol—Rash—Prednisolone—chronic obstructive pulmonary disease	4.89e-05	0.00045	CcSEcCtD
Bisoprolol—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.88e-05	0.00045	CcSEcCtD
Bisoprolol—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.86e-05	0.000448	CcSEcCtD
Bisoprolol—Headache—Prednisolone—chronic obstructive pulmonary disease	4.86e-05	0.000448	CcSEcCtD
Bisoprolol—Constipation—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000444	CcSEcCtD
Bisoprolol—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.8e-05	0.00442	CbGpPWpGaD
Bisoprolol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.7e-05	0.00432	CbGpPWpGaD
Bisoprolol—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.64e-05	0.000428	CcSEcCtD
Bisoprolol—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.64e-05	0.00427	CbGpPWpGaD
Bisoprolol—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.61e-05	0.000425	CcSEcCtD
Bisoprolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.61e-05	0.000424	CcSEcCtD
Bisoprolol—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000412	CcSEcCtD
Bisoprolol—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.00041	CcSEcCtD
Bisoprolol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.45e-05	0.00041	CcSEcCtD
Bisoprolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.23e-05	0.0039	CbGpPWpGaD
Bisoprolol—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	4.22e-05	0.00389	CbGpPWpGaD
Bisoprolol—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.15e-05	0.000382	CcSEcCtD
Bisoprolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.12e-05	0.00379	CbGpPWpGaD
Bisoprolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.04e-05	0.000372	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	4.03e-05	0.00371	CbGpPWpGaD
Bisoprolol—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.99e-05	0.000367	CcSEcCtD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	3.96e-05	0.00365	CbGpPWpGaD
Bisoprolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.85e-05	0.000355	CcSEcCtD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.81e-05	0.0035	CbGpPWpGaD
Bisoprolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000343	CcSEcCtD
Bisoprolol—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.72e-05	0.00343	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.68e-05	0.00339	CbGpPWpGaD
Bisoprolol—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.58e-05	0.00033	CcSEcCtD
Bisoprolol—Rash—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000327	CcSEcCtD
Bisoprolol—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000327	CcSEcCtD
Bisoprolol—Headache—Prednisone—chronic obstructive pulmonary disease	3.53e-05	0.000325	CcSEcCtD
Bisoprolol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.41e-05	0.00314	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	3.39e-05	0.00312	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.38e-05	0.00311	CbGpPWpGaD
Bisoprolol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.37e-05	0.0031	CbGpPWpGaD
Bisoprolol—Nausea—Prednisone—chronic obstructive pulmonary disease	3.35e-05	0.000308	CcSEcCtD
Bisoprolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	3.3e-05	0.00304	CbGpPWpGaD
Bisoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.1e-05	0.00285	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.09e-05	0.00285	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.05e-05	0.00281	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.03e-05	0.00279	CbGpPWpGaD
Bisoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.03e-05	0.00279	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.97e-05	0.00273	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.89e-05	0.00266	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	2.83e-05	0.0026	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.77e-05	0.00255	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.00244	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.62e-05	0.00241	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	2.6e-05	0.00239	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.58e-05	0.00238	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.58e-05	0.00238	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	2.57e-05	0.00236	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.54e-05	0.00234	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.43e-05	0.00224	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.41e-05	0.00221	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.37e-05	0.00218	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.34e-05	0.00215	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.33e-05	0.00214	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.31e-05	0.00213	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.28e-05	0.0021	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.26e-05	0.00208	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.00207	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.22e-05	0.00204	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.11e-05	0.00195	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.07e-05	0.0019	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.04e-05	0.00188	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.02e-05	0.00186	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.02e-05	0.00186	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2e-05	0.00184	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.99e-05	0.00184	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.98e-05	0.00182	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.81e-05	0.00166	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.69e-05	0.00155	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.66e-05	0.00153	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.00151	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.00148	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.55e-05	0.00143	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.55e-05	0.00143	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.53e-05	0.00141	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.52e-05	0.0014	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.00135	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.46e-05	0.00134	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.45e-05	0.00133	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.33e-05	0.00122	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.31e-05	0.0012	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.28e-05	0.00118	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.25e-05	0.00115	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.25e-05	0.00115	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.22e-05	0.00112	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.00112	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.2e-05	0.0011	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.19e-05	0.00109	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.18e-05	0.00109	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.17e-05	0.00107	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.16e-05	0.00107	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.00105	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.12e-05	0.00103	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.08e-05	0.000997	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.04e-05	0.000954	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.01e-05	0.000934	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.13e-06	0.000841	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.93e-06	0.000822	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.49e-06	0.000782	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.31e-06	0.000764	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.84e-06	0.000721	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.83e-06	0.000721	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	7.62e-06	0.000701	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.08e-06	0.000652	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.05e-06	0.000649	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7e-06	0.000645	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.9e-06	0.000635	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.85e-06	0.00063	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.41e-06	0.00059	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.37e-06	0.000586	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.36e-06	0.000586	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.29e-06	0.000579	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.27e-06	0.000577	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.23e-06	0.000573	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.13e-06	0.000564	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.99e-06	0.000552	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.74e-06	0.000529	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.7e-06	0.000524	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.57e-06	0.000513	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.29e-06	0.000487	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.68e-06	0.000431	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.58e-06	0.000422	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.47e-06	0.000411	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.41e-06	0.000406	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.37e-06	0.000402	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.35e-06	0.000401	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.27e-06	0.000393	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.17e-06	0.000384	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.16e-06	0.000383	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.11e-06	0.000379	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.06e-06	0.000373	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.84e-06	0.000354	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.78e-06	0.000348	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.75e-06	0.000346	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.7e-06	0.000341	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.6e-06	0.000331	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.52e-06	0.000324	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.46e-06	0.000318	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.42e-06	0.000315	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.35e-06	0.000308	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.07e-06	0.000283	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.01e-06	0.000277	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.89e-06	0.000266	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.85e-06	0.000262	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.82e-06	0.00026	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.77e-06	0.000255	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.76e-06	0.000254	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.71e-06	0.000249	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.65e-06	0.000244	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.61e-06	0.000241	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.51e-06	0.000231	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.5e-06	0.00023	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.32e-06	0.000214	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.27e-06	0.000209	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.13e-06	0.000196	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.08e-06	0.000191	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.71e-06	0.000157	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.63e-06	0.00015	CbGpPWpGaD
